Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics-Reference-Cited by-同舟云学术

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics

Published:2015-10-06 Issue:12 Volume:90 Page:1128-1134
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Glimelius Ingrid¹²,Ekberg Sara¹³,Jerkeman Mats⁴,Chang Ellen T.⁵,Björkholm Magnus⁶,Andersson Therese M.L.³,Smedby Karin E.¹,Eloranta Sandra¹

Affiliation:

1. Department of Medicine; Clinical Epidemiology Unit, Karolinska Institutet and Karolinska University Hospital; Stockholm Sweden

2. Department of Immunology, Genetics and Pathology Clinical and Experimental Oncology; Uppsala University and Uppsala Akademiska Hospital; Sweden

3. Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden

4. Department of Oncology; Skåne University Hospital; Lund Sweden

5. California and Department of Health Research and Policy; Health Sciences Practice, Exponent, Inc., Menlo Park, Stanford University School of Medicine; Stanford California

6. Department of Medicine Division of Hematology; Karolinska University Hospital and Karolinska Institutet; Stockholm Sweden

Funder

The Swedish Society of Medicine

The Swedish Society for Medical Research

The Strategic research Program in Epidemiology at Karolinska Institutet

Publisher

Wiley

Subject

Hematology

Reference34 articles.

1. Trends in survival in hodgkin lymphoma: the effect of better management;Bjorkholm;Eur Hematol Assoc Hematol Educ Prog,2014

2. Treatment of Hodgkin lymphoma: a 50-year perspective;Canellos;J Clin Oncol Off J Am Soc Clin Oncol,2014

3. Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects;Ng;Blood,2014

4. Limited-stage hodgkin lymphoma: managing uncertainty;Meyer;J Clin Oncol Off J Am Soc Clin Oncol,2014

5. Are patients with Hodgkin lymphoma and high-grade non-Hodgkin lymphoma in clinical therapy optimization protocols representative of these groups of patients in Germany?;Terschuren;Ann Oncol: Off J Eur Soc Med Oncol/ESMO,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating cure proportion in cancer clinical trials using flexible parametric cure models;BJC Reports;2024-08-28

2. Evidence of being cured for nasopharyngeal carcinoma: results of a multicenter patient-based study in China;The Lancet Regional Health - Western Pacific;2024-08

3. Estimating the long-term survival of unresectable stage III non-small cell lung cancer based on cure model analysis;Radiotherapy and Oncology;2024-08

4. Treatment approaches for older Hodgkin lymphoma patients;Current Opinion in Oncology;2024-06-20

5. Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study;British Journal of Haematology;2024-06-12